a five-year, $100 million commitment by Bristol-Myers Squibb Company - in partnership with governments, physicians, and community-based groups in Botswana, Namibia, Lesotho, and Swaziland - to find sustainable and relevant solutions for the management of HIV/AIDS in women and children, and to provide resources to improve community education and patient support.